Table 2.

Clinical characteristics and telomerase measurements in CD3+ T- cells myelodysplastic syndrome (MDS) cases.

N=35			RTL*		hTERT$		TA#
Characteristic	n	%	mean (SD)	p-value	mean (SD)	p-value	mean (SD)	p-value
IPSS** score
Low+int-1	21	60	1.08 (0.10)		14.42 (1.53)		14.43 (1.31)
Int-2+high	14	40	1.36 (0.13)	0.10	10.45 (1.97)	0.12	10.96 (1.14)	0.06
Cytogenetics
Normal	15	43	1.07 (0.08)		12.72 (2.00)		12.59 (1.36)
Abnormal	20	57	1.36 (0.12)	0.07	13.38 (1.71)	0.80	13.62 (1.35)	0.60
WHO## MDS subtype
MDSU+RARS	6	17	1.45 (0.23)		17.39 (4.95)		13.05 (2.85)
RCMD	15	43	1.11 (0.09)		12.58 (1.72)		13.74 (1.53)
RAEB1+RAEB2	14	40	1.25 (1.46)	0.33	11.76 (1.62)	0.31	12.55 (1.35)	0.85

^*RTL=Relative telomere length;

^$hTERT= Human telomerase reverse transcriptase

^#TA=Telomerase activity;

^**IPSS=International Prognostic Scoring System;

^##WHO=World Health Organization